CSIMarket Company Name, Ticker, Industry, else..


Amicus Therapeutics inc   (NASDAQ: FOLD)
Other Ticker:  
 

Amicus Therapeutics inc

FOLD's Fundamental analysis



Looking into Amicus Therapeutics Inc growth rates, revenue grew by 37.72 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 390

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.75 %

Amicus Therapeutics Inc net loss decreased from $-22 millions, to $-7 millions in III. Quarter 2024,

• More on FOLD's Growth


Amicus Therapeutics Inc
realized a net loss in trailing twelve months.

Amicus Therapeutics Inc realized cash reduction of $ -0.1 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.81.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.01.


• More on FOLD's Valuation
 
 Total Debt (Millions $) 389
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 976,828
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.68
 Tangible Book Value (Per Share $) -0.12

Amicus Therapeutics Inc
realized net loss in trailing twelve months.

Amicus Therapeutics Inc realized cash outflow of $ -0.1per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.81.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.01.

Amicus Therapeutics Inc Price to Book Ratio is at 16.03 lower than Industry Avg. of 77.58. and higher than S&P 500 Avg. of 0.01

• More on FOLD's Valuation

•  Market Capitalization (Millions $) 2,867
•  Shares Outstanding (Millions) 305
•  Employees 505
•  Revenues (TTM) (Millions $) 493
•  Net Income (TTM) (Millions $) -105
•  Cash Flow (TTM) (Millions $) -29
•  Capital Exp. (TTM) (Millions $) -5
•  Total Debt (Millions $) 389
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 976,828
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 5.68
•  Tangible Book Value (Per Share $) -0.12

•  Market Capitalization (Millions $) 2,867
•  Shares Outstanding (Millions) 305
•  Employees 505
•  Revenues (TTM) (Millions $) 493
•  Net Income (TTM) (Millions $) -105
•  Cash Flow (TTM) (Millions $) -29
•  Capital Exp. (TTM) (Millions $) -5


    FOLD's Profitability Comparisons
Amicus Therapeutics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 15.34 % from 11.84 % in II. Quarter.



  Ratio
•   Capital Ratio (MRQ) 3.15
•  Total Debt to Equity (MRQ) 2.18
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.65
•  Inventory Turnover Ratio (TTM) 0.62



Amicus Therapeutics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 15.34 % from 11.84 % in II. Quarter.



• More on FOLD's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com